Company / Cash & Equivalents
OCTAVE SPECIALTY GROUP INC Cash & Equivalents History
FY2011-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$29.6M
FY2024
5-year range
$20.0M / $63.0M
FY2020-FY2024
Trend
+48.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents returned to growth in FY2024 after 2 years of decline, reaching $30M.
Based on SEC 10-K filings.
$30M in FY2024 with a 5-year CAGR of +4.3%.
Improved from $24M to $30M over the past 5 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +4.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +4.3%, indicating consistent growth.
- In FY2024, cash & equivalents increased 48.0% year-over-year.
- Peak cash & equivalents was recorded in FY2018.
- Lowest cash & equivalents in the period was in FY2011.
Company context
Key Data Points
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $29.6M | +48.0% |
| FY2020 | $20.0M | -16.7% |
| FY2019 | $24.0M | -61.9% |
| FY2018 | $63.0M | +43.7% |
| FY2012 | $43.8M | +361.6% |
| FY2011 | $9.5M | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026